Apellis Pharmaceuticals, Inc. · NASDAQ:APLS

Biogen Inc. reported a 0% stake in Apellis Pharmaceuticals, Inc. (Schedule 13D/A)

Event May 14, 2026 · Filed May 14, 2026

Biogen Inc. reported a 0% stake in Apellis Pharmaceuticals, Inc., 0 shares, with active intent on May 14, 2026. Filed May 14, 2026 (Schedule 13D/A).

Stake
0%
Shares
0
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Biogen Inc.0%0

Source

View original at SEC

Related